Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Location: United States, Massachusetts, Boston
Employees: 51-200
Total raised: $1M
Founded date: 2001
Investors 5
Date | Name | Website |
- | Domain Ass... | domainvc.c... |
- | DBL Partne... | dbl.vc |
08.05.2021 | DBL Partne... | dblpartner... |
- | Lightstone... | lightstone... |
- | TPG | tpg.com |
Funding Rounds 1
Date | Series | Amount | Investors |
25.05.2010 | - | $1M | - |
Mentions in press and media 9
Date | Title | Description | Source |
09.03.2021 | Five Prime Cancels Fourth Quarter and Full-Year 2020 Financi... | SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 9, 2021-- Five Prime Therapeutics, Inc. (NASDAQ: ... | oaoa.com/n... |
19.02.2020 | Drug at center of $1.7B BMS, Five Prime partnership fails in... | The partnership between the two companies had been announced in October 2015 and was focused on the ... | medcitynew... |
29.07.2013 | Five Prime Therapeutics pitches $60M IPO after string of pha... | Five Prime Therapeutics wants to follow more than two dozen other drug developers this year onto the... | fiercebiot... |
18.04.2012 | GSK, FivePrime partner to discover new asthma and COPD treat... | Over the next four years, privately held FivePrime stands to gain up to $30 million from the new dea... | medcitynew... |
25.05.2010 | Five Prime Therapeutics Receives $1M to Develop Candidate fo... | Five Prime Therapeutics, Inc., a San Francisco, CA-based developer of innovative protein and antibod... | finsmes.co... |
- | Drug at center of $1.7B BMS, Five Prime partnership fails in... | A clinical trial that was a big part of a more than $1 billion partnership between a large drugmaker... | medcitynew... |
- | GSK, FivePrime partner to discover new asthma and COPD treat... | GlaxoSmithKline (NYSE:GSK) is partnering with California biotechnology company Five Prime Therapeuti... | medcitynew... |
- | Five Prime Therapeutics Announces Timing of Its Fourth Quart... | SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 2, 2021-- Five Prime Therapeutics, Inc. (NASDAQ: ... | oaoa.com/n... |
- | Five Prime Therapeutics to Participate in the Cowen 41st Ann... | SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 26, 2021-- Five Prime Therapeutics, Inc. (NASDAQ:... | oaoa.com/n... |